Dr. Reddy’s Laboratories Ltd. ADR (NYSE: RDY) is -11.53% lower on its value in year-to-date trading and has touched a low of $13.36 and a high of $16.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RDY stock was last observed hovering at around $13.84 in the last trading session, with the day’s gains setting it 0.13%.
Currently trading at $13.97, the stock is -3.76% and -4.83% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.0 million and changing 0.94% at the moment leaves the stock -7.72% off its SMA200. RDY registered -3.24% loss for a year compared to 6-month loss of -13.54%. The firm has a 50-day simple moving average (SMA 50) of $14.686 and a 200-day simple moving average (SMA200) of $15.14041.
The stock witnessed a -9.52% gain in the last 1 month and extending the period to 3 months gives it a -5.95%, and is 3.33% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.03% over the week and 1.67% over the month.
Dr. Reddy’s Laboratories Ltd. ADR (RDY) has around 27048 employees, a market worth around $11.64B and $3.72B in sales. Current P/E ratio is 18.17 and Fwd P/E is 17.32. Profit margin for the company is 17.25%. Distance from 52-week low is 4.57% and -17.30% from its 52-week high. The company has generated returns on investments over the last 12 months (16.88%).
with sales reaching $83.23B over the same period.The EPS is expected to shrink by -1.96% this year, but quarterly earnings will post 15.90% year-over-year. Quarterly sales are estimated to grow 17.50% in year-over-year returns.
The shares outstanding are 834.42M, and float is at 833.06M with Short Float at 1.45%.
The top institutional shareholder in the company is JPMORGAN CHASE & CO with over 0.64 million shares valued at $48.67 million. The investor’s holdings represent 1.9149 of the RDY Shares outstanding. As of 2024-06-30, the second largest holder is ROBECO INSTITUTIONAL ASSET MANAGEMENT B.V. with 2.07 million shares valued at $157.65 million to account for 1.2427 of the shares outstanding. The other top investors are ROYAL BANK OF CANADA which holds 2.06 million shares representing 1.2345 and valued at over $156.61 million, while MORGAN STANLEY holds 1.2191 of the shares totaling 2.03 million with a market value of $154.67 million.
